Physician

Hans Frederick Otto, M.D.

According to 2025 Medicare claims, Hans Otto, M.D. (NPI: 1215924477) practices allergy/immunology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Kenton, KY. This provider's primary affiliated billing organization is PSF PLLC (NPI: 1881785947; TIN: 611389493) and primary practice location at 41042-4852.

Otto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 223 traditional Medicare patients, billed 23,967 HCPCS/CPT codes, and received $371,360 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,207 prescription claims across 263 beneficiaries totaling $405,444 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 39 claims. Open Payments data shows 180 records totaling $110,496. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $51,881 to $371,360. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $122,114 to $405,444. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $779 and ending at $613.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	165	5,442	$51,881
2016	203	5,436	$54,478
2017	237	7,546	$86,218
2018	260	5,842	$59,664
2019	304	9,809	$115,586
2020	248	9,028	$139,248
2021	304	13,005	$190,675
2022	200	10,296	$156,087
2023	204	17,943	$294,285
2024	223	23,967	$371,360

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	111	764	$122,114
2016	119	830	$139,510
2017	135	944	$152,159
2018	159	1,029	$203,837
2019	171	1,143	$209,241
2020	185	1,192	$289,365
2021	221	1,135	$311,749
2022	191	1,085	$379,131
2023	221	915	$285,564
2024	263	1,207	$405,444

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	63	$4,566
2016	N/R	105	$7,592
2017	N/R	87	$5,262
2018	N/R	104	$14,693
2019	N/R	126	$16,791
2020	N/R	68	$34,856
2021	N/R	119	$44,116
2022	N/R	66	$39,152
2023	N/R	65	$37,520
2024	N/R	39	$37,683

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	38	38	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	54	66	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	35	41	$62
95165	Professional service for preparation and provision of 1 or more antigens	118	2,790	$10
95117	Professional service for multiple injections of allergen	131	2,449	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	14	616	$79,820
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	100	3,180	$67,065
Tezspire	Tezepelumab-Ekko	13	364	$53,689
Nucala	Mepolizumab	11	308	$47,069
Xolair	Omalizumab	12	336	$31,392

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$37,069
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	13	$518
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	13	$95

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	180	$110,496	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hans Frederick Otto, M.D.?

Tedicare shows public-source Medicare data for Hans Frederick Otto, M.D. (NPI 1215924477), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hans Frederick Otto, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hans Frederick Otto, M.D.?

Hans Frederick Otto, M.D. is linked to PSF PLLC (billing NPI 1881785947) in the available physician profile data.

Does Hans Frederick Otto, M.D. have Open Payments data?

Hans Frederick Otto, M.D. has 180 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.